MétaCan
Menu
Back to cohort
Record W2595098826 · doi:10.3324/haematol.2016.156356

Improved survival after acute graft- <i>versus</i> -host disease diagnosis in the modern era

2017· article· en· W2595098826 on OpenAlexaff
H. Jean Khoury, Tao Wang, Michael Hemmer, Daniel Couriel, Amin M. Alousi, Corey Cutler, Mahmoud Aljurf, Joseph H. Antin, Mouhab Ayas, Minoo Battiwalla, Jean‐Yves Cahn, Mitchell S. Cairo, Yi‐Bin Chen, Robert Peter Gale, Shahrukh K. Hashmi, Robert J. Hayashi, Madan Jagasia, Mark Juckett, Rammurti T. Kamble, Mohamed A. Kharfan‐Dabaja, Mark R. Litzow, Navneet S. Majhail, Alan M. Miller, Taiga Nishihori, Muna Qayed, Hélène Schoemans, Harry C. Schouten, Gèrard Socié, Jan Storek, Leo F. Verdonck, Ravi Vij, William A. Wood, Lolie C. Yu, Rodrigo Martino, Matthew Carabasi, Christopher E. Dandoy, Usama Gergis, Peiman Hematti, Melham Solh, Kareem Jamani, Leslie Lehmann, Bipin N. Savani, Kirk R. Schultz, Baldeep Wirk, Stephen R. Spellman, Mukta Arora, Joseph Pidala

Bibliographic record

VenueHaematologica · 2017
Typearticle
Languageen
FieldMedicine
TopicHematopoietic Stem Cell Transplantation
Canadian institutionsBC Children's HospitalUniversity of British ColumbiaUniversity of Calgary
FundersNational Institute of Allergy and Infectious DiseasesOffice of Naval ResearchGenentechHealth Resources and Services AdministrationSwedish Orphan BiovitrumOtsuka PharmaceuticalAstellas PharmaOtsuka Americabluebird bioJanssen Scientific AffairsTelomere DiagnosticsSunesisMedacJazz PharmaceuticalsMedical College of WisconsinTakeda OncologyUniversity of MinnesotaSpectrum PharmaceuticalsAlexion PharmaceuticalsU.S. NavyCelgeneNational Center for Advancing Translational SciencesHistoGeneticsWellPointOnyx PharmaceuticalsU.S. Department of DefenseSanofiBristol-Myers SquibbAstraZenecaU.S. Department of Health and Human ServicesAstellas Pharma USAmgenNational Heart, Lung, and Blood InstituteNovartis Pharmaceuticals CorporationIncytePfizerPatient-Centered Outcomes Research InstituteNational Cancer InstituteGilead Sciences
KeywordsMedicineGraft-versus-host diseaseAcute leukemiaDiseaseInternal medicineTransplantationHematopoietic stem cell transplantationCohortMyelodysplastic syndromesMyeloid leukemiaRegimenGastroenterologySurgeryLeukemiaImmunologyBone marrow

Abstract

fetched live from OpenAlex

A cute graft-versus-host disease remains a major threat to a successful outcome after allogeneic hematopoietic cell transplantation. While improvements in treatment and supportive care have occurred, it is unknown whether these advances have resulted in improved outcome specifically among those diagnosed with acute graft-versus-host disease. We examined outcome following diagnosis of grade II-IV acute graft-versus-host disease according to time period, and explored effects according to original graft-versus-host disease prophylaxis regimen and maximum overall grade of acute graft-versus-host disease. Between 1999 and 2012, 2,905 patients with acute myeloid leukemia (56%), acute lymphoblastic leukemia (30%) or myelodysplastic syndromes (14%) received a sibling (24%) or unrelated donor (76%) blood (66%) or marrow (34%) transplant and developed grade II-IV acute graft-versus-host disease (n=497 for 1999–2001, n=962 for 2002–2005, n=1,446 for 2006–2010). The median (range) follow-up was 144 (4–174), 97 (4–147) and 60 (8–99) months for 1999–2001, 2002–2005, and 2006–2010, respectively. Among the cohort with grade II-IV acute graft-versus-host disease, there was a decrease in the proportion of grade III-IV disease over time with 56%, 47%, and 37% for 1999–2001, 2002–2005, and 2006–2012, respectively (P

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.035
GPT teacher head0.301
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations109
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueHaematologicaSame topicHematopoietic Stem Cell TransplantationFrench-language works237,207